Blood Vessel Regeneration, also known as angiogenesis, is a critical process in the body's ability to repair and restore vascular networks. This dynamic phenomenon involves the growth of new blood vessels from existing ones, contributing to tissue healing, development, and adaptation. Various factors, including tissue injury, ischemia, or the body's response to increased metabolic demands, can trigger angiogenesis. Endothelial cells, lining the inner walls of blood vessels, play a central role in this process, proliferating and migrating to form new capillaries, arteries, and veins. The regulation of blood vessel regeneration involves an intricate interplay of signaling molecules, growth factors, and cellular interactions. Vascular endothelial growth factor (VEGF) is a key player in promoting angiogenesis by stimulating endothelial cell proliferation and migration. Blood vessel regeneration is essential for wound healing, tissue repair, and the recovery from ischemic events such as heart attacks or strokes. Conversely, abnormal angiogenesis is associated with various diseases, including cancer, where it promotes tumor growth and metastasis. Researchers explore innovative approaches to enhance blood vessel regeneration, including the use of biomaterials, stem cells, and gene therapies. Understanding the molecular mechanisms and cellular processes involved in angiogenesis is crucial for developing therapeutic interventions to promote or inhibit blood vessel formation, depending on the clinical context.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Will be updated soon...
Vasiliki E Kalodimou, European University-Cyprus Ltd, Cyprus
Title : Will be updated soon...
Nagy Habib, Imperial College London, United Kingdom
Title : Will be updated soon...
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : Advanced 3D tissue models: Pioneering tools for investigating health and disease
Lucie Bacakova, Institute of Physiology of the Czech Academy of Sciences, Czech Republic
Title : Developing iPSC-derived 3D Outer Blood-Retinal Barrier Disease Models of Choroideremia for Gene Therapy Evaluation
Aradhana Kasimsetty, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), United States